Manulife (Manufacturers Life Insurance)
AGIO icon

Manulife (Manufacturers Life Insurance)’s Agios Pharmaceuticals AGIO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
50,046
-20,210
-29% -$573K ﹤0.01% 1564
2025
Q4 		$1.92M Sell
70,256
-25,756
-27% -$904K ﹤0.01% 1538
2025
Q3 		$3.85M Sell
96,012
-36,071
-27% -$1.36M ﹤0.01% 1281
2025
Q2 		$4.39M Buy
132,083
+512
+0.4% +$15.5K ﹤0.01% 1222
2025
Q1 		$3.86M Buy
131,571
+9,477
+8% +$314K ﹤0.01% 1274
2024
Q4 		$4.01M Sell
122,094
-21,337
-15% -$1M ﹤0.01% 1286
2024
Q3 		$6.37M Buy
143,431
+5,587
+4% +$254K 0.01% 1106
2024
Q2 		$5.94M Buy
137,844
+48,835
+55% +$1.76M 0.01% 1087
2024
Q1 		$2.6M Buy
89,009
+39,331
+79% +$1.05M ﹤0.01% 1427
2023
Q4 		$1.11M Sell
49,678
-538
-1% -$12.1K ﹤0.01% 1745
2023
Q3 		$1.24M Buy
50,216
+2,612
+5% +$69.1K ﹤0.01% 1620
2023
Q2 		$1.35M Buy
47,604
+590
+1% +$14.7K ﹤0.01% 1525
2023
Q1 		$1.08M Sell
47,014
-8,139
-15% -$216K ﹤0.01% 1598
2022
Q4 		$1.53M Sell
55,153
-43
-0.1% -$1.21K ﹤0.01% 1459
2022
Q3 		$1.57M Sell
55,196
-390
-0.7% -$10.5K ﹤0.01% 1446
2022
Q2 		$1.24M Buy
55,586
+723
+1% +$16.3K ﹤0.01% 1555
2022
Q1 		$1.61M Buy
54,863
+26,702
+95% +$816K ﹤0.01% 1563
2021
Q4 		$936 Sell
28,161
-2,525
-8% -$102K ﹤0.01% 1875
2021
Q3 		$1.42M Sell
30,686
-4,144
-12% -$200K ﹤0.01% 1635
2021
Q2 		$1.92M Buy
+34,830
New +$1.95M ﹤0.01% 1635
2018
Q3 		– Sell
-1,681
Closed -$141K – 2939
2018
Q2 		$141K Buy
1,681
+13
+0.8% +$1.13K ﹤0.01% 3325
2018
Q1 		$136K Buy
1,668
+185
+12% +$14.3K ﹤0.01% 3296
2017
Q4 		$85K Buy
1,483
+18
+1% +$1.13K ﹤0.01% 3441
2017
Q3 		$98K Buy
1,465
+324
+28% +$19.5K ﹤0.01% 3329
2017
Q2 		$59K Buy
1,141
+70
+7% +$3.58K ﹤0.01% 3449
2017
Q1 		$63K Hold
1,071
– – ﹤0.01% 3301
2016
Q4 		$45K Buy
1,071
+17
+2% +$892 ﹤0.01% 3440
2016
Q3 		$56K Sell
1,054
-6
-0.6% -$261 ﹤0.01% 3370
2016
Q2 		$44K Buy
1,060
+6
+0.6% +$296 ﹤0.01% 3391
2016
Q1 		$40K Hold
1,054
– – ﹤0.01% 3346
2015
Q4 		$68 Hold
1,054
– – ﹤0.01% 3212
2015
Q3 		$74 Sell
1,054
-10
-0.9% -$977 ﹤0.01% 3236
2015
Q2 		$118 Sell
1,064
-8,957
-89% -$965K ﹤0.01% 3234
2015
Q1 		$945 Buy
10,021
+671
+7% +$75.2K ﹤0.01% 1717
2014
Q4 		$1.05K Buy
9,350
+5
+0.1% +$446 ﹤0.01% 1553
2014
Q3 		$573 Buy
9,345
+150
+2% +$6.46K ﹤0.01% 1901
2014
Q2 		$422K Buy
9,195
+3,184
+53% +$130K ﹤0.01% 2160
2014
Q1 		$235 Buy
6,011
+562
+10% +$18.8K ﹤0.01% 2603
2013
Q4 		$130 Buy
5,449
+5,265
+2,861% +$120K ﹤0.01% 2963
2013
Q3 		$5 Buy
+184
New +$5.08K ﹤0.01% 3348

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AGIO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Agios Pharmaceuticals (AGIO) stake by 29% in Q1 2026, selling an estimated $573K and leaving 50,046 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Manulife (Manufacturers Life Insurance) first reported a position in AGIO in Q3 2013 and has held it in 40 quarters since. The position peaked at $6.37M in Q3 2024. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 50,046 shares of Agios Pharmaceuticals worth $1.69M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 20,210 Agios Pharmaceuticals shares in Q1 2026, an estimated $573K.
  • Agios Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1564 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 40 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Agios Pharmaceuticals position peaked at $6.37M in Q3 2024.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.